These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2015-004257-41 PEANUT ALLERGY ORAL IMMUNOTHERAPY STUDY OF AR101 FOR DESENSITIZATION IN CHILDREN AND ADULTS (THE PALISADE STUDY) 2018-07-02 due-trials
Reported results 2016-004941-94 PEANUT ALLERGY ORAL IMMUNOTHERAPY STUDY OF AR101 FOR DESENSITIZATION IN CHILDREN AND ADULTS (PALISADE) FOLLOW-ON STUDY 2019-05-31 due-trials
Reported results 2016-005004-26 AR101 TRIAL IN EUROPE MEASURING ORAL IMMUNOTHERAPY SUCCESS IN PEANUT ALLERGIC CHILDREN (ARTEMIS) 2019-02-15 due-trials
Listed as ongoing, but also has a completion date 2017-001334-26 A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY 2023-04-28 bad-data
Listed as ongoing, but also has a completion date 2018-000326-58 Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adolescents: Real-World, Open-Label, Quality of Life Study 2018-11-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2018-001749-15 Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON) 2022-07-05 bad-data
Trial is outside EEC, and reported results 2021-002087-47 Oral Desensitization to Peanut in Peanut-Allergic Children and Adults using Characterized Peanut Allergen (CPNA) Oral Immunotherapy (OIT) bad-data
Trial is outside EEC, and reported results 2021-002533-42 Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen (CPNA) Peanut Oral Immunotherapy (OIT) Safety Follow-On Study bad-data